Deutsche Bank Remains Optimistic on Mead Johnson (MJN) After Q4 Print, Boosts PT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall Street indexes fall, with Iran and earnings season in focus
- Oil settles 1% higher as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Miller Tabak Downgrades Mead Johnson Nutrition (MJN) to Neutral
February 1, 2013 8:56 AM ESTMiller Tabak downgraded Mead Johnson Nutrition (NYSE: MJN) from Buy to Neutral with a price target of $76.00 following Q4 results.
For an analyst ratings summary and ratings history on Mead Johnson Nutrition... More
Mead Johnson (MJN) Tops Q4 EPS by 4c, Gives FY13 Guidance
January 31, 2013 7:40 AM ESTMead Johnson Nutrition Co. (NYSE: MJN) reported Q4 EPS of $0.72, $0.04 better than the analyst estimate of $0.68. Revenue for the quarter came in at $981.1 million versus the consensus estimate of $953.84 million.
Mead Johnson Nutrition Co. sees FY2013 EPS of $3.22-3.30, versus the consensus of $3.33.... More
